Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 10, 2015 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial – Evaluation of Airway sGaw after treatment with tripLE

Takefumi Saito1 Department of Respiratory Medicine, Ibarakihigashi National Hospital, Naka, Ibaraki, Japan

Akinori Takeda2 Center for Pulmonary Medicine, Asahikawa Medical Center, Asahikawa, Hokkaido, Japan

Katsuji Hashimoto3 AMC Nishiumeda Clinic, Osaka, Japan

Akihiro Kobayashi4 Biomedical Science Department, GlaxoSmithKline KK, Tokyo, Japan

Tomoyuki Hayamizu5 Medical Affairs Respiratory Department, GlaxoSmithKline KK, Tokyo, JapanCorrespondence[email protected]

Gerald W Hagan6 Independent Consultant, Marbella, Spain

Pages 2393-2404 | Published online: 04 Nov 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Global Initiative for Chronic Obstructive Lung Disease (GOLD) Revised ed 20112014 Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2014_Jan23.pdf
Google Scholar
BetsuyakuTKatoMFujimotoKA study to assess COPD symptom-based management and to optimise treatment strategy in Japan (COSMOS-J) based on GOLD 2011Int J Chron Obstruct Pulmon Dis2013845345924124358
PubMed Web of Science ®Google Scholar
The Japanese Respiratory SocietyGuidelines for the Diagnosis and Treatment of COPD4th edTokyo, JapanJapanese Respiratory Society2013
Google Scholar
SinghDBrooksJHaganGCahnAO’ConnorBJSuperiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPDThorax200863759259818245142
PubMed Web of Science ®Google Scholar
BourbeauJChristodoulopoulosPMaltaisFYamauchiYOlivensteinRHamidQEffect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomized controlled trialThorax2007621193894317557771
PubMed Web of Science ®Google Scholar
JohnsonMCorticosteroids: potential beta2-agonist and anticholinergic interactions in chronic obstructive pulmonary diseaseProc Am Thorac Soc20052432032516267356
PubMedGoogle Scholar
LittnerMRIlowiteJSTashkinDPLong-acting bronchodilation with once daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20001614 Pt 11136114210764302
PubMed Web of Science ®Google Scholar
CasaburiRMahlerDAJonesPWA long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J20021921722411866001
PubMed Web of Science ®Google Scholar
HoshinoMOhtawaJEffects of adding salmeterol/fluticasone propionate to tiotropium on airway dimensions in patients with chronic obstructive pulmonary diseaseRespirology20111619510120920142
PubMed Web of Science ®Google Scholar
CazzolaMAndòFSantusPA pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPDPulm Pharmacol Ther200720555656116914336
PubMed Web of Science ®Google Scholar
HoshinoMOhtawaJEffects of tiotropium and salmeterol/fluticasone propionate on airway wall thickness in chronic obstructive pulmonary diseaseRespiration201386428028723880883
PubMed Web of Science ®Google Scholar
JungKSParkHYParkSYfor Korean Academy of Tuberculosis and Respiratory Diseases study groupKorea Chronic Obstructive Pulmonary Disease study groupComparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled studyRespir Med2012106338238921975275
PubMed Web of Science ®Google Scholar
HananiaNACraterGDMorrisANEmmettAHO’DellDMNiewoehnerDEBenefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPDRespir Med201210619110122040533
PubMed Web of Science ®Google Scholar
WilliamsEJExperimental designs balanced for the estimation of residual effects of treatmentsAust J Sci Res Ser A19492149168
Google Scholar
BorrillZLHoughtonCMTal-SingerRThe use of plethysmography and oscillometry to compare long acting bronchodilators in patients with COPDBr J Clin Pharmacol200865224425218251761
PubMed Web of Science ®Google Scholar
KenwardMGRogersJHSmall sample inference for fixed effects from restricted maximum likelihoodBiometrics19975339839979333350
PubMed Web of Science ®Google Scholar
BorrillZHoughtonCWoodcockAAVestboJSinghDMeasuring bronchodilation in COPD clinical trialsBr J Clin Pharmacol200559437938415801931
PubMed Web of Science ®Google Scholar
van NoordJASmeetsJClementJVan de WoestijneKPDemedtsMAssessment of reversibility of airflow obstructionAm J Respir Crit Care Med199415025515548049845
PubMed Web of Science ®Google Scholar
LarbonisADelwicheJ-PJamartJVandenplasOComparison of FEV1 and specific airway conductance in assessing airway response to occupational agentsAllergy2003581256126014616100
PubMed Web of Science ®Google Scholar
MacklemPTMeadJResistance of central and peripheral airways measured by a retrograde catheterJ Appl Physiol19672233954014960137
PubMed Web of Science ®Google Scholar
BouhuysAVan De WoestijneKPRespiratory mechanics and dust exposure in byssinosisJ Clin Invest19704911061185409799
PubMed Web of Science ®Google Scholar
VillarBPomboVBronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary diseaseArch Bronconeumol200541313013415766465
PubMed Web of Science ®Google Scholar
AaronSDVandemheenKLFergussonDCanadian Thoracic Society/Canadian Respiratory Clinical Research ConsortiumTiotropium in combination with placebo, salmeterol, or fluticasone–salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trialAnn Intern Med2007146854555517310045
PubMed Web of Science ®Google Scholar
ShortPMWilliamsonPAElderDHJLipworthSIWSchembriSLipworthBJThe impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting β-agonist therapy in COPDChest20121411818621799028
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial – Evaluation of Airway sGaw after treatment with tripLE

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial – Evaluation of Airway sGaw after treatment with tripLE

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date